These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 37542683)

  • 1. Osteoporosis and Fracture Risk among Older US Asian Adults.
    Lo JC; Yang W; Park-Sigal JJ; Ott SM
    Curr Osteoporos Rep; 2023 Oct; 21(5):592-608. PubMed ID: 37542683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
    Black DM; Geiger EJ; Eastell R; Vittinghoff E; Li BH; Ryan DS; Dell RM; Adams AL
    N Engl J Med; 2020 Aug; 383(8):743-753. PubMed ID: 32813950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Race/Ethnicity on United States FRAX Calculations and Treatment Qualification: A Registry-Based Study.
    Leslie WD;
    J Bone Miner Res; 2023 Dec; 38(12):1742-1748. PubMed ID: 37548387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
    Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
    Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate use after clinical fracture and risk of new fracture.
    Bergman J; Nordström A; Nordström P
    Osteoporos Int; 2018 Apr; 29(4):937-945. PubMed ID: 29397408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective risk of osteoporotic fractures in patients with advanced chronic obstructive pulmonary disease.
    Gupta A; Greening NJ; Evans RA; Samuels A; Toms N; Steiner MC
    Chron Respir Dis; 2019; 16():1479972318769763. PubMed ID: 29661041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of treatment strategies and thresholds for optimizing fracture prevention in Canada: a simulation analysis.
    Leslie WD; Morin SN; Lix LM; Binkley N
    Arch Osteoporos; 2019 Dec; 15(1):4. PubMed ID: 31858278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinician's guide to prevention and treatment of osteoporosis.
    LeBoff MS; Greenspan SL; Insogna KL; Lewiecki EM; Saag KG; Singer AJ; Siris ES
    Osteoporos Int; 2022 Oct; 33(10):2049-2102. PubMed ID: 35478046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics, bone mineral density and non-vertebral osteoporotic fracture outcomes among post-menopausal U.S. South Asian Women.
    Khandelwal S; Chandra M; Lo JC
    Bone; 2012 Dec; 51(6):1025-8. PubMed ID: 22921875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for older men with fractures.
    Shepherd AJ; Cass AR; Ray LA; Tan A; Wilkinson GS
    Osteoporos Int; 2012 Mar; 23(3):1041-51. PubMed ID: 21811867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Hip Fracture Despite Treatment with Bisphosphonates among Frail Older Adults.
    Zullo AR; Sorial MN; Lee Y; Lary CW; Kiel DP; Berry SD
    J Am Geriatr Soc; 2020 Feb; 68(2):256-260. PubMed ID: 31580488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Hansen L; Petersen KD; Eriksen SA; Gerstoft F; Vestergaard P
    Osteoporos Int; 2017 Jan; 28(1):321-328. PubMed ID: 27475930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate use and subsequent hip fracture in South Korea.
    Lee YK; Ha YC; Choi HJ; Jang S; Park C; Lim YT; Shin CS
    Osteoporos Int; 2013 Nov; 24(11):2887-92. PubMed ID: 23681088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study.
    Condurache CI; Chiu S; Chotiyarnwong P; Johansson H; Shepstone L; Lenaghan E; Cooper C; Clarke S; Khioe RFS; Fordham R; Gittoes N; Harvey I; Harvey NC; Heawood A; Holland R; Howe A; Kanis JA; Marshall T; O'Neill TW; Peters TJ; Redmond NM; Torgerson D; Turner D; McCloskey E;
    Osteoporos Int; 2020 Mar; 31(3):457-464. PubMed ID: 31960099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.
    Desai RJ; Mahesri M; Abdia Y; Barberio J; Tong A; Zhang D; Mavros P; Kim SC; Franklin JM
    JAMA Netw Open; 2018 Jul; 1(3):e180826. PubMed ID: 30646034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice.
    Leslie WD; Majumdar SR; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
    Osteoporos Int; 2012 Jan; 23(1):391-7. PubMed ID: 21365460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
    Wang CC; Lu HT; Dusetzina SB; Wu CH
    J Womens Health (Larchmt); 2016 Jul; 25(7):738-46. PubMed ID: 27096405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability.
    McCloskey EV; Fitzpatrick LA; Hu MY; Williams G; Kanis JA
    Arch Osteoporos; 2019 Feb; 14(1):15. PubMed ID: 30719589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical risk factor status in patients with vertebral fracture but normal bone mineral density.
    Kadri A; Binkley N; Daffner SD; Anderson PA
    Spine J; 2022 Oct; 22(10):1634-1641. PubMed ID: 35680015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.